PetCaseFinder

Peer-reviewed veterinary case report

Thrombocytopenia and platelet antibodies in 83 dogs studied 2004-2006

By Dircks, Brigitte Hedwig et al.·Published in Journal of the American Veterinary Medical Association·2009·Small Animal Clinic, Germany·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Underlying diseases and clinicopathologic variables of thrombocytopenic dogs with and without platelet-bound antibodies detected by use of a flow cytometric assay: 83 cases (2004-2006).

Species:
dog

Plain-English summary

A group of 83 dogs with low platelet counts (thrombocytopenia) was studied to understand their underlying health issues. About 45% of these dogs had antibodies attached to their platelets, which can indicate a condition called immune-mediated thrombocytopenia (IMT). Dogs with these antibodies had significantly lower platelet counts compared to those without them. The study found that examining bone marrow could help determine if a dog has primary IMT, as many of those dogs showed increased production of platelet-producing cells. Understanding these factors can help veterinarians better diagnose and treat dogs with low platelet counts.

People also search for: dog low platelet count symptoms · immune-mediated thrombocytopenia treatment · dog bone marrow analysis results

Abstract

OBJECTIVE: To characterize underlying diseases and clinical and clinicopathologic variables of thrombocytopenic dogs with and without platelet-bound antibodies (PBAs) and to evaluate clinicopathologic variables of dogs with primary immune-mediated thrombocytopenia (IMT). DESIGN: Retrospective case series. ANIMALS: 83 thrombocytopenic dogs. PROCEDURES: Medical records were reviewed to identify dogs in which PBA tests were performed between 2004 and 2006; PBAs were measured via flow cytometry. RESULTS: PBAs were detected in 37 of 83 (45%) dogs. Thirteen dogs were suspected of having primary IMT. Median platelet counts were significantly lower in dogs with PBAs, compared with counts in dogs without PBAs. Dogs suspected of having primary IMT had significantly lower median platelet counts, compared with counts for those with secondary IMT. Mean platelet volume (MPV) was increased (> 14.3 fL) significantly more often in dogs without PBAs (19/33 [58%]) than in dogs with PBAs (7/26 [27%]). No dogs suspected of having primary IMT had an increase in MPV. Examination of bone marrow aspirates revealed an increase in megakaryopoiesis in a higher percentage of dogs with PBAs (14/21 [67%]) than in dogs without PBAs (7/18 [39%]). An increase in megakaryopoiesis was detected in all dogs suspected of having primary IMT that had a bone marrow analysis. CONCLUSIONS AND CLINICAL RELEVANCE: Platelet counts, results of bone marrow analysis, and MPV may be helpful in dogs for the differentiation between primary IMT and thrombocytopenia resulting from other diseases. An MPV within or less than the reference range did not rule out an increase in megakaryopoietic activity.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/19827982/